Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Klein

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Current Gene Therapy|January 16, 2013
Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspectiveQiang Bai, Romain Desprat, Bernard Klein, et al.
Cell Cycle (Georgetown, Tex.)|May 3, 2017
Hypoxia favors the generation of human plasma cellsMatthieu Schoenhals, Michel Jourdan, Angélique Bruyer, et al.
Biochemical and Biophysical Research Communications|December 7, 2007
CD200: a putative therapeutic target in cancerJérôme Moreaux, Jean Luc Veyrune, Thierry Reme, et al.
British Journal of Haematology|November 15, 2013
DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidineJerome Moreaux, Angelique Bruyer, Jean-Luc Veyrune, et al.
Biochemical and Biophysical Research Communications|March 10, 2009
Embryonic stem cell markers expression in cancersMatthieu Schoenhals, Alboukadel Kassambara, John De Vos, et al.
Plos Computational Biology|January 31, 2015
GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cellsAlboukadel Kassambara, Thierry Rème, Michel Jourdan, et al.
Oncogene|May 29, 2003
A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cellsMichel Jourdan, Jean-Luc Veyrune, John De Vos, et al.
Experimental Hematology|September 22, 2010
MYEOV is a prognostic factor in multiple myelomaJerome Moreaux, Dirk Hose, Amélie Bonnefond, et al.
British Journal of Cancer|February 12, 2016
Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myelomaElena Viziteu, Camille Grandmougin, Hartmut Goldschmidt, et al.
Cytometry. Part B, Clinical Cytometry|September 3, 2017
Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometryElina Alaterre, Sébastien Raimbault, Jean-Michel Garcia, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Current Gene Therapy|January 16, 2013
Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspectiveQiang Bai, Romain Desprat, Bernard Klein, et al.
Cell Cycle (Georgetown, Tex.)|May 3, 2017
Hypoxia favors the generation of human plasma cellsMatthieu Schoenhals, Michel Jourdan, Angélique Bruyer, et al.
Biochemical and Biophysical Research Communications|December 7, 2007
CD200: a putative therapeutic target in cancerJérôme Moreaux, Jean Luc Veyrune, Thierry Reme, et al.
British Journal of Haematology|November 15, 2013
DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidineJerome Moreaux, Angelique Bruyer, Jean-Luc Veyrune, et al.
Biochemical and Biophysical Research Communications|March 10, 2009
Embryonic stem cell markers expression in cancersMatthieu Schoenhals, Alboukadel Kassambara, John De Vos, et al.
Plos Computational Biology|January 31, 2015
GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cellsAlboukadel Kassambara, Thierry Rème, Michel Jourdan, et al.
Oncogene|May 29, 2003
A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cellsMichel Jourdan, Jean-Luc Veyrune, John De Vos, et al.
Experimental Hematology|September 22, 2010
MYEOV is a prognostic factor in multiple myelomaJerome Moreaux, Dirk Hose, Amélie Bonnefond, et al.
British Journal of Cancer|February 12, 2016
Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myelomaElena Viziteu, Camille Grandmougin, Hartmut Goldschmidt, et al.
Cytometry. Part B, Clinical Cytometry|September 3, 2017
Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometryElina Alaterre, Sébastien Raimbault, Jean-Michel Garcia, et al.
Pageof 13